Introduction
Cells transformed by several oncogenes have been reported to show dierent patterns of gene expression from the original non-transformed cells, suggesting that oncogene products modulate the endogenous transcriptional factors for the maintenance of cellular transformation. Among these transcriptional factors, AP-1 has been reported to play important roles in several transformed cells (Angel and Karin, 1991) . AP-1 is composed of Fos (Cohen and Curran, 1988; Zerial et al., 1989; Nishina et al., 1990; Matsui et al., 1990) and Jun family proteins (Nishimura and Vogt, 1988; Nathans, 1988, 1989; Hirai et al., 1989) . Any member of Fos can form a heterodimeric complex with any member of Jun, and all the resultant complexes bind to speci®c DNA sequences known as AP-1 binding sites (Halazonetis et al., 1988; Sassone-Corsi et al., 1988; Nakabeppu et al., 1988; Suzuki et al., 1991b) . Using dominant-negative mutants of Fos and Jun family proteins that function as general inhibitors of AP-1, we have previously shown that activation of endogenous AP-1 is essential for cellular transformation by a wide variety of transforming genes, such as vsrc, v-yes, v-fps, c-Ha-ras and activated by c-raf (Okuno et al., 1991; Suzuki et al., 1994) . The major AP-1 constituent in these transformed cells was shown by gel shift analysis to be the Fra-2/c-Jun heterodimer . Comparative analysis of AP-1 components in transformed and non-transformed CEF further indicated that expression levels of c-Jun and Fra-2 are elevated (two to four fold) in the transformed cells. Fra-2 is also highly phosphorylated in ras-, rafand especially v-src-transformed CEF .
Fra-2 was originally identi®ed in growth-stimulated CEF as one of the Fos-related antigens (Nishina et al., 1990) . After growth stimulation, the expression of Fra-2 was drastically induced at a slightly later time than that of c-Fos (Nishina et al., 1990; Sonobe et al., 1995) . Unlike c-Fos, Fra-2 was detectable even in growth-arrested or logarithmically growing CEF as smear bands which correspond to either slightly phosphorylated forms or non-phosphorylated form (40 kDa) (Yoshida et al., 1991) . We reported previously that, like the expression level, the level of Fra-2 phosphorylation was promptly and transiently elevated by growth stimulation, and further, this hyperphosphorylated form shows a mobility shift to an apparent molecular weight of 46 kDa (Yoshida et al., 1991; Sonobe et al., 1995) . The apparent molecular weight was reduced to 40 kDa by alkaline phosphatase treatment (Yoshida et al., 1991; .
By DNA sequence analysis of the fra-2 promoter region, enhancer consensus sequences such as SCM (sis conditioned medium response element, or SIE (sis inducible element)), SRE (serum response element), GC boxes and a CRE (cAMP response element)-like sequence were detected upstream of the TATA-like sequence in the same order as that in the 5'-upstream region of the chicken c-fos gene (Yoshida et al., 1993) . Transient expression experiments in CEF using a series of promoter deletion constructs positioned upstream of the chloramphenicol acetyl transferase (CAT) reporter gene indicated that two typical AP-1 binding sequences, which are located between the major transcriptional initiation site and the coding sequence, and the CRE-like sequence are the major enhancers responsible for the fra-2 induction by serum (Sonobe et al., 1995) . When transiently introduced into mouse embryo carcinoma cell line F9 with the fra-2 promoter-CAT as well as 16TRE-CAT which contained a single AP-1 binding site from the collagenase gene, c-fos plus c-jun stimulated the transactivation as compared with c-jun alone (Suzuki et al., 1991b; Sonobe et al., 1995) . This property of c-Fos is in clear contrast to that of Fra-2, which suppresses the transcriptional activity of c-Jun by forming a stable heterodimer. These results suggested that fra-2 induction by growth stimulation is auto-or cross-regulated by the relative amounts of cFos and Fra-2 proteins in the CEF (Sonobe et al., 1995) .
To elucidate the molecular mechanisms involved in the modulation of Fra-2 function in v-src transformed CEF, we examined protein kinases responsible for Fra-2 phosphorylation in v-src transformed cells and identi®ed ERK2 as the major Fra-2 kinase. Since JNKs were also reported to be involved in the transformation by v-src or v-ras in mouse cells (Hibi et al., 1993; Xie and Herschman, 1995) , we also tested whether these kinases are involved in the phosphorylation of Fra-2 protein. Finally, we examined the molecular mechanisms of the elevation of the Fra-2 expression level in v-src transformed cells by fra-2 promoter analysis.
Results

Hyperphosphorylation of Fra-2 in v-src transformed CEF
As chicken fos/jun family genes, c-fos (Fujiwara et al., 1987) , fra-2 (Nishina et al., 1990) (fos family), c-jun (Nishimura and Vogt, 1988) and junD (Hartl et al., 1991) (jun family) have been detected and cloned so far. To elucidate the activation mechanisms of endogenous AP-1 in v-src transformed CEF, we started with an analysis of the protein components that bind to a consensus AP-1 binding site. CEF infected with N4 (carrying v-src) or DS3 (empty vector) were labeled with 35 S-methionine and nuclear extracts were prepared and applied to latex beads, which were conjugated with the AP-1 binding site in the promoter of the collagenase gene (TGAGTCA). After extensive washing, bound proteins were eluted and resolved on 10% SDS ± PAGE (Figure 1a) . The proteins were puri®ed by DNA anity chromatography, then sequentially immunoprecipitated with a series of speci®c antisera which recognize JunD, Jun family proteins, Fra-2 and Fos family proteins. As shown in Figure 1b , Fra-2, c-Jun and JunD were major components, while only a marginal amount of c-Fos was detected in each case. Two protein bands with molecular weights of 58 kDa and 60 kDa were copuri®ed with AP-1 complexes speci®cally in v-src transformed CEF (Figure 1a ). Since these bands were copuri®ed even on DNA anity chromatography with a mutated AP-1 binding site (GGGGTCA) (data not shown), we did not analyse these proteins further. Several other protein bands were detected in both nontransformed and v-src-transformed CEF, but they did not belong to the Fos or Jun family, because they were not crossreactive to several other antibodies which recognize Fos or Jun family proteins (data not shown). Some of them might be ATF, Maf or other leucine zipper family proteins; the relative amounts were rather similar in the two cell types.
Relative amounts of Fra-2 and c-Jun in v-src transformed CEF were signi®cantly higher compared with non-transformed CEF (Figure 1b) , consistent with the previous observation that transcripts of c-jun and fra-2, as well as their gene products, were enhanced in v-src transformed CEF . Fra-2 proteins in v-src transformed cells formed a main band of 46 kDa, together with smear bands (42 ± 44 kDa), while most of the Fra-2 in non-transformed CEF was in the lower smear bands, con®rming the previous observation that Fra-2 becomes highly phosphorylated after v-src transformation, which is accompanied with the mobility shift of the protein bands ). Since we were not able to detect any qualitative changes of the proteins that bind to AP-1 binding sites, other than Fra-2 hyperphosphorylation, in either of the cell types, we concentrated on the analysis of the molecular mechanisms involved in hyperphosphorylation of Fra-2 and the elevation of fra-2 expression in v-src transformed cells. v-src transformation, as well as growth stimulation, induces the kinase activity that phosphorylates a Fra-2 C-terminal region in vitro
To determine which region of Fra-2 protein was phosphorylated in v-src transformed cells, we constructed a series of Fra-2 deletion mutants that were fused to GST at their N-termini (Figure 2a ). These proteins were expressed in E. coli and used as substrates of the kinase reaction (Figure 2b ). Lysates were prepared from v-src transformed CEF or DS3-infected CEF and added to a kinase reaction mixtures containing the Fra-2 deletion mutants immobilized on the glutathione Sepharose beads. Very strong activity for the phosphorylation of such Fra-2 proteins as the full length Fra-2 (GST-F2 (1 ± 323)) and GST-F2 (1 ± 287) was detected in the cell lysate of v-src transformed CEF, but not in that from DS3-infected CEF ( Figure  3 , upper panel). The other substrates containing Fra-2 fragments except GST-F2 (1 ± 58) were also phosphorylated speci®cally by cell lysates of v-src transformed cells, but their phosphorylation levels were much lower. These results indicate that the major phosphorylation sites are localized at the C-terminal region of Fra-2. A Fra-2 C-terminal region, GST-F2 (215 ± 323) was also found to be a good substrate for this kinase activity (data not shown). Phosphoamino acid analysis of GST-F2 (1 ± 323) and GST-F2 (215 ± 323) phosphorylated in vitro indicated that both Ser (*30%) and Thr (*70%) residues were phosphorylated. Since the Fra-2 protein immunoprecipitated from v-src transformed CEF metabolically labeled with inorganic 32 P-phosphate was also phosphorylated on both Ser (*70%) and Thr (*30%) residues, the Fra-2 kinase(s) appears tö ]ATP, together with the GST-Fra-2 substrates. 32 P-Labeled proteins were boiled in SDS solution, applied to a 10% polyacrylamide gel and detected by autoradiography (middle panel). Protein kinase reactions by lysates from growth-arrested (7) or growth-stimulated (+) CEF assayed as described above (lower panel). Protein kinase reactions by lysates from logarithmically growing CEF without (7) or with (+) u.v. irradiation (20 J/m 2 ). For the detection of protein bands, ®lms were exposed 3 times longer than those in the upper and middle panels be a Ser/Thr kinase. When the cell lysates prepared from growth-stimulated CEF or growth-arrested CEF were used for the kinase reaction instead, the full length Fra-2 (GST-F2 (1 ± 323)) and GST-F2 (1 ± 287) were again extensively phosphorylated speci®cally by the lysates from growth-stimulated CEF ( Figure 3 , middle panel) on Ser (*30%) and Thr (*70%) residues. We reported previously that growth stimulation caused Fra-2 phosphorylation predominantly on Ser residues (Yoshida et al., 1991) . This discrepancy might be accounted for by dephosphorylation during cell lysate preparation and immunoprecipitation, because we did not use protein phosphatase inhibitors in the previous experiments.
Fra-2 C-terminal region is phosphorylated by a 42 kDa protein kinase, which is absorbed by anti-ERK2 antiserum
To identify the protein kinases responsible for the ecient phosphorylation of Ser and Thr residues in the Fra-2 C-terminal region, cell lysates were prepared from serum-starved or growth-stimulated CEF and CEF infected with control virus or v-src virus and they were subjected to an in gel kinase assay. As shown in Figure 4 , the same set of several protein bands was detectable in all the lysates, both in the gel without substrate (left panel) and in the gel containing GST-F2 (215 ± 323) (right panel), indicating that these bands were labeled by autophosphorylation. In the gel containing GST-F2 (215 ± 323) (right panel), however, a unique protein band of 42 kDa was detected speci®cally in the lysates from v-src-transformed CEF or growth-stimulated CEF but not control virus or serum-starved CEF.
MAP kinases, which belong to the class of Ser/Thr kinases, have been shown to be activated by growth stimulation or transformation, and the molecular weights of the non-active (non-phosphorylated) forms of mammalian MAP kinases, ERK2 and ERK1, were reported to be 41 and 43 kDa, respectively (Ray and Sturgill, 1987; Hoshi et al., 1988; Gotoh et al., 1990a,b; Nishida and Gotoh, 1991) . To test the possibility that the 42 kDa protein kinase induced by growth stimulation is one of the chicken MAP kinases, the induction kinetics of MAP kinase activity and Fra-2 Cterminal kinase activity were compared after growth stimulation. Induction of a single band of 42 kDa was detected in a gel containing MBP which is a good substrate for MAP kinase (Gotoh et al., 1990a (Gotoh et al., ,b, 1991 ( Figure 5 , upper panel) and this 42 kDa protein kinase activity was also detected with quite similar induction kinetics in a gel containing GST-F2 (215 ± 323) ( Figure  5 , lower panel). From the growth-stimulated CEF, anti-mouse ERK2 antiserum speci®cally precipitated a single 42 kDa band with MAP kinase activity, indicating that the active form of the chicken ERK2 has a molecular weight of 42 kDa ( Figure 5 , last lane). Western blotting analysis of growth-stimulated CEF and rat PC12 cell lysates with a mixture of anti-ERK1 antibody and anti-ERK2 antibody, detected a doublet band (41 ± 42 kDa) in CEF and two doublets (41 ± 42 kDa and 43 ± 44 Da) in PC12 cells (data not shown). The doublet in CEF was similar in molecular weight to the non-active and active forms of rat ERK2 (41 ± 42 kDa). These results are consistent with the fact that only a single protein, ERK2, has been reported as chicken MAP kinase (Sanghera et al., 1992; Greulich et al., 1996) . Puri®ed activated MAP kinase also phosphorylated the Fra-2 deletion mutants with the same substrate speci®city as the kinase activity induced by v-src transformation or growth stimulation ( Figure  6a and Figure 3 , upper and middle panels). As shown in Figure 6b , after absorption of ERK2 by anti-ERK2 antiserum, Fra-2 kinase activity in the cell lysates of vsrc transformed CEF and growth-stimulated CEF was drastically reduced to 10% and 16%, respectively. Thus, we concluded that the major component responsible for Fra-2 phosphorylation in these lysates was MAP kinase (ERK2).
Phosphorylation of endogenous Fra-2 protein
Fra-2 protein bands in v-src transformed CEF or in growth-stimulated CEF showed a clear mobility shift to the apparent molecular weight of 46 kDa. It is noteworthy, however, that GST-Fra-2 protein did not show a clear mobility shift after phosphorylation in vitro: the 32 P-labeled Fra-2 band comigrated with the non-phosphorylated substrate detected by staining with Coomassie brilliant blue (data not shown). This might be explained by assuming that the puri®ed MAP kinase or the lysates used here were not able to phosphorylate fully the substrate GST-Fra2, because in all the in vitro assays described above, the substrate was added to excess to detect the dierence in the kinase activity. So we performed a modi®ed kinase reaction in which the amount of puri®ed MAP kinase and the reaction time were increased fourfold and eightfold, respectively, while the amount of the substrate was reduced to 10%. When protein bands were detected by Western blotting using anti-Fra-2 pep2 antiserum (Figure 7a ), a clear mobility shift of (1 ± 323) or GST-F2 (215 ± 323) was phosphorylated by puri®ed activated MAP kinase (+) or not phosphorylated (7). After SDS ± PAGE, the proteins were transferred from the gel to polyvinylidene di¯uoride membrane and detected by Western blotting using anti-Fra-2 peptide 2 antibody. (b) Comparative analysis of tryptic digests of Fra-2 protein in v-src transformed CEF metabolically labeled in vivo and GST-F2 (1 ± 323) labeled in vitro by cell lysates from v-src transformed CEF. After digestion, each peptide sample was resolved on 20% SDS ± PAGE and detected by autoradiography. (c) Mobility shift of Fra-2 deletion mutants induced by growth stimulation in vivo. HA-tagged Fra-2 deletion mutants were introduced into CEF by using retrovirus vectors. Before (7) or after (+) growth stimulation, whole cell lysates were prepared and analysed by Western blotting using anti-HA monoclonal antibody. Two protein bands of 52 kDa and 79 kDa were non-speci®c signals GST-F2 (1 ± 323) or GST-F2 (215 ± 323) was observed after the kinase reaction. These results indicate that the C-terminal region alone (amino acids 215 ± 323) is sucient for this mobility shift and further that multiple sites in this region are indeed phosphorylated by ERK2. The GST-Fra2 (1 ± 323) phosphorylated by the lysate of v-src transformed CEF in vitro was isolated and its tryptic digests were compared with those of metabolically 32 P-phosphorylated endogenous Fra-2 protein which was immunoprecipitated from v-src transformed CEF. Both of them contained a few small peptides which migrated similarly (Figure 7b) . The tryptic digests of Fra-2 phosphorylated in vitro, however, additionally contained several slowly migrating peptides (Figure 7b ) which were resistant to further digestion by this protease (data not shown). A similar migration pattern of the digests was also observed when Fra-2 was isolated from growth-stimulated CEF (data not shown). These results suggest that ERK2 is the major protein kinase responsible for Fra-2 phosphorylation in vivo, and further that some residues in Fra-2 are phosphorylated by ERK2 but not phosphorylated in vivo. To localize the region that is intensively phosphorylated in vivo more de®nitively, we made use of retrovirus vectors that express a series of mutant Fra-2 proteins that were fused to an HA-tag at their N-terminal end to discriminate them from the endogenous Fra-2. The protein bands of HA-F2 (1 ± 323), HA-F2 (1 ± 287) and HA-F2 (97 ± 323) detected in the serum-starved conditions were drastically reduced after growth stimulation and more slowly migrating bands appeared instead (Figure 7c ). HA-F2 (1 ± 265), however, did not show any mobility shift after growth stimulation. These results indicate that the C-terminal region (amino acids 266 ± 323) contains the intensively phosphorylated sites of the Fra-2 protein in CEF, as observed in in vitro kinase assays. In v-src transformed CEF, however, the mobility shift of these HA-Fra-2 mutants was much less clear (data not shown). This might be partly because the MAP kinase activity is much higher in growth-stimulated CEF than in v-src transformed CEF (Figure 4 and Figure 8 , middle and lower panels) and partly because the amount of the substrate, Fra-2, was greatly increased in CEF infected with the retrovirus vectors.
JNKs can not phosphorylate Fra-2
JNKs (Jun N-terminal kinases) belong to the MAP kinase family of protein kinases , and were reported to be able to phosphorylate c-Jun (Hibi et al., 1993; DeÂ rijard et al., 1994; Sluss et al., 1994; Kyriakis et al., 1994; Karin, 1995) , AFT-2 (Gupta et al., 1995; Livingstone et al., 1995) and Elk (Gille et al., 1995; Whitmarsh et al., 1995; Zinck et al., 1995) . Since JNK activity was reported to be induced by u.v. irradiation, proin¯ammatory cytokines, or various stress factors, as well as growth stimulation or cellular transformation (Hibi et al., 1993; Raitano et al., 1995; Xie and Herschman, 1995) , we tested whether endogenous JNK activity is elevated in v-src transformed CEF and whether JNKs could also phosphorylate Fra-2 or not. By means of in gel kinase assay using a c-Jun N-terminal region as the substrate, we estimated the endogenous JNK activity in v-src-transformed CEF and DS3-infected CEF. We were not able to detect signi®cant elevation of JNK-1 (46 kDa) or JNK-2 (54 kDa) activity in vsrc transformed cells, while u.v. irradiation or growth stimulation caused dramatic induction of these activities (Figure 8, upper panel) . When GST-F2 (1 ± 323) or GST-F2 (1 ± 287) was used as the substrate, low but speci®c phosphorylation of Fra-2 was detected in the cell lysates from logarithmically growing CEF, but it was not dependent on u.v. irradiation (Figure 3, lower panel) . This kinase activity was mostly removed by preabsorption with anti-ERK2 antiserum (data not shown), indicating that Fra-2 phosphorylation is mainly attributable to ERK2 activity which is present at a moderate level in the logarithmically growing cells independently of u.v. irradiation. The in gel kinase assay using MBP (Figure 8, middle panel) or GST-F2 (215 ± 323) (Figure 8, lower panel) as the substrates con®rmed To determine the enhancer sequences in the fra-2 promoter region that are responsible for the elevation of fra-2 expression in v-src transformed cells, reporter plasmids containing fra-2 promoter deletion mutants were transfected into v-src transformed CEF and CAT activity was determined. As can be seen by comparing the results with pFT6 and pFT8.0 (Figure 9) , deletion of both SCM and SRE sequences had no eect on the CAT activity. The reporter with intact AP-1 binding sites and a mutated CRE-like sequence (pFT8.4) showed a signi®cantly reduced CAT activity compared with its parental plasmid pFT8.0. The promoter activity become marginal when the two AP-1 sites were additionally mutated (pFT8.5). The importance of these two AP-1 sites was con®rmed by comparing pFT9.0 with the intact AP-1 sites and its variant pFT9.1 with mutations in both of the AP-1 binding sites. These results indicate that the CRE-like sequence and the two AP-1 binding sites mediate the elevation of fra-2 expression by v-src.
Discussion
We have analysed the molecular mechanisms that induce Fra-2 phosphorylation and expression in v-src transformed cells. In the whole cell lysates, we detected MAP kinase (ERK2) as a major Fra-2 protein kinase activity that is inducible by cellular transformation and growth stimulation. Puri®ed MAP kinase phosphorylates at several Ser and Thr residues in the C-terminal region (amino acids 266 ± 323) of Fra-2 protein, leading to a mobility shift of the Fra-2 protein on SDS ± PAGE, as is observed in v-src transformed CEF or growth-stimulated CEF. The tryptic digests of Fra-2 phosphorylated in vitro contained several peptides that have apparently similar molecular weights in SDS ± PAGE to those of Fra-2 isolated from v-src transformed CEF (Figure 7b ) or growth-stimulated CEF (data not shown). A similar result was previously reported for Fra-2 isolated from growth-stimulated mouse 3T3 cells and Fra-2 treated with puri®ed MAP kinase in vitro (Gruda et al., 1994) . We further con®rmed that the C-terminal region (amino acids 266 ± 323) is responsible for the mobility shift in vivo, using HA-tagged Fra-2 mutants expressed by retrovirus vectors.
It should also be pointed out, however, that Fra-2 labeled in vitro contained several additional 32 p-labeled tryptic peptides which were not found in Fra-2 labeled in v-src transformed cells. It has been reported that cFos protein changes its susceptibility to several protein kinases after forming dimers with c-Jun or binding to DNA in vitro (Abate et al., 1993) . These observations would partly explain the phosphorylation residues in Fra-2 are more restricted in vivo.
Analysis of the fra-2 promoter region identi®ed two AP-1 binding sites and a CRE-like sequence as major enhancer sequences that support the high level expression of this gene in v-src transformed CEF. By means of transient expression experiments in F9 cells, we showed previously that all of these enhancers respond to cotransfection of the cells with expression vectors encoding the AP-1 components; c-Fos plus cJun induced higher expression from the fra-2 promoter than c-Jun alone, while Fra-2 plus c-Jun supported only lower expression levels than c-Jun alone (Sonobe et al., 1995) . Considering that Fra-2 and c-Jun are the major components in v-src transformed CEF, in which fra-2 expression is elevated through the AP-1 binding sites and CRE-like sequence, these results seem contradictory. We hypothesize that phosphorylation of Fra-2 by ERK2 converts it from an inecient transcriptional activator to an active one. The heterodimer between phosphorylated Fra-2 and endogenous c-Jun is expected to transactivate several genes, including the fra-2 gene, through the AP-1 binding sites. Indeed, like unphosphorylated Fra-2, highly phosphorylated Fra-2 can form stable heterodimer with c-Jun (Sonobe et al., 1995) and is detectable in anity puri®ed AP-1 fractions (Figure 1) .
As we have previously reported, v-yes, v-fps, c-Haras and activated c-raf also cause elevation of both fra-2 gene expression and Fra-2 phosphorylation although to lesser extents . CEF transformed by these oncogenes have higher levels of MAP kinase activity than that of non-transformed CEF (our unpublished results). The good correlation between the level of Fra-2 phosphorylation and that of fra-2 expression further supports the hypothesis that fra-2 is autoregulated by the phosphorylation status of its gene product through the AP-1 binding sites present in its own promoter.
Although the C-terminal region of Fra-2 (amino acids 266 ± 323) contains two representative phosphorylation sites of MAP kinase (Pro-Ala-Ile-Thr-Pro and Pro-Leu-Ser-Pro), the Fra-2 mutant in which the Ser or Thr residues in both of the representative consensus sites were substituted to Ala was still a substrate of MAP kinase both in vivo and in vitro (our unpublished results), the three dipeptides of Ser/Thr-Pro (a broad Figure 9 Schematic representation of fra-2 promoter deletion-CAT reporter plasmids (left panel) and their CAT activity in v-src transformed CEF (right panel). Wild-type and mutated enhancer sequences are shown as closed and open boxes, respectively. v-src transformed CEF were transfected with each reporter plasmid and the CAT activity was assayed 48 h after transfection. Each value is the average of duplicate determinations. CAT activity is shown as percentage conversion to the acetylated forms phosphorylation consensus of MAP kinase) in this region are also expected to be phosphorylated. It is noteworthy that all of these ®ve consensus sequences found in chicken Fra-2 are completely conserved in mouse and human Fra-2 proteins (Matsui et al., 1990; Foletta et al., 1994) .
Some kinase reactions using cell lysates of v-src transformed CEF revealed the presence of some kinase activity that can phosphorylate Fra-2 lacking the Cterminal region (amino acids 266 ± 323). Although this kinase activity is absent in both non-transformed CEF and growth-stimulated CEF, its properties were left unknown. Since other members of the MAP kinase family, JNK1 and JNK2, have been reported to be activated by cellular transformation (Hibi et al., 1993; Xie et al., 1995; Raitano et al., 1995) as well as stress factors or growth stimulation, we next determined the level of JNK activity by in gel kinase assay. While both JNK1 and JNK2 were activated by u.v. irradiation or growth stimulation, their steady-state levels were not signi®cantly changed by v-src transformation in CEF, as analysed by in gel kinase assays. These results are consistent with the previous report that phosphorylation levels of endogenous c-Jun at the N-terminal region are not much changed by v-src transformation in CEF (Catling et al., 1993) . We also found that the basal level of JNK activity in growing CEF is rather high compared with that of mouse ®broblasts (our unpublished data). Furthermore, Fra-2 does not seem to be a good substrate for JNKs, because its phosphorylation level was not elevated by u.v. irradiation, which causes a drastic induction of JNK activity. From these results we conclude that Fra-2 phosphorylation by MAP kinase, rather than c-Jun phosphorylation by JNK, plays a key role in the activation of endogenous AP-1 activity in v-src transformed CEF.
Materials and methods
Puri®cation of AP-1 complexes
Nuclear extracts from 35 S-labeled CEF were prepared by Dignam's method with slight modi®cations (Dignam et al., 1983) . Two complementary oligonucleotides containing the collagenase TRE site, 5'-AAGCATGAGTCAGACACCCC-3' and 5'-GGGGTTCGTACTCAGTCTGT-3', were chemically synthesized, 5'-phosphorylated, annealed, and ligated to give oligomers that ranged in size from 150 to 250 bp, as previously described (Kawaguchi et al., 1989) . Latex beads carrying these oligomers were prepared as described previously (Inomata et al., 1992) . Nuclear extracts were mixed with 3 mg of poly(dI-dC) and 20 mg of salmon sperm DNA. The mixture was incubated at 48C for 1 h, added to latex beads and further incubated at 48C for 2 h. The beads were washed ®ve times with buer (50 mM HEPES-KOH (pH 7.9), 20% glycerol, 1 mM EDTA, 10 mM DTT, 0.3 M NaCl, 0.1% NP-40, 5 mM Na 3 VO 4 and 10 mM NaF) containing a mixture of protease inhibitors (0.1 mg/ml antipain, 0.1 mg/ml leupeptin, 1 mM PMSF, and 1% Trasylol). Bound proteins were eluted with the same buer containing 1 M NaCl.
Plasmid construction
The chicken fra-2 cDNA was molecularly cloned from pRSV2-Fra-2 (Suzuki et al., 1991b) by the PCR technique, using a 5' primer that contains the initiation codon with base changes (underlined) to give a Kozak concensus sequence (5'-CCAGATATCCACCATGGGCCAGGAC-TATCCCGGGAG-3') and a 3' primer that contains the stop codon of the gene (5'-CCGGATATCGTTA-CAATGCCAGCAAGGTG-3'). The PCR products were digested at EcoRV sites present in the primers (bold letters) and inserted into the unique EcoRV site of pDS3 in the sense orientation to generate pDS3-fra-2C. The DNA sequence of the EcoRV insert was con®rmed by the dideoxynucleotide method using the Bcabest sequence kit (TaKaRa). The expression vector for the full length Fra-2 fused to GST at its N-terminal (pGEX-F2 (1 ± 323)) was constructed by inserting the EcoRV fragment (encoding the entire Fra-2 (amino acids 1 ± 323)) isolated from pDS3-fra-2C into the SmaI site of pGEX 4T-1 (Pharmacia). The EcoRV fragments were further digested with PstI, PvuII, Ecl136II, BsrBI, BstEII, or HinfI, treated with Klenow fragment (in the case of BstEII and HinfI digestions) or S1 nuclease (in the case of PstI digestions) and cloned into the SmaI site of pGEX4T-1 to generate pGEX-F2 (1 ± 58), F2 (1 ± 118), F2 (1 ± 172), F2 (1 ± 213), F2 (1 ± 265) and F2 (1 ± 287), respectively. The expression vector for the Fra-2 C-terminal region (215 ± 323) fused to GST at its N-terminus, pGEX-F2 (215 ± 232), was constructed by inserting the BsrBI-EcoRV fragment from pDS3-fra-2C into the SmaI site of pGEX4T-1.
For the construction of the retrovirus vectors which contain an HA-tag at the N-terminus of Fra-2, the following pair of complementary oligonucleotide was synthesized, annealed, and ligated into the BglII site of the modi®ed pDS3 Suzuki et al., 1994) in which the unique XhoI site was disrupted:
The generated plasmid, pDS3-HA contains the Kozak consensus sequence for initiation of translation followed by a coding sequence (MYPYDVPDYA) from in¯uenza hemagglutinin (HA) and further by NcoI, EcoRV and XhoI cloning sites, and stop codons in all frames. The NcoI-SalI fragments of pGEX-F2 and its deletion mutants which contain the fra-2 initiation codon was inserted into the NcoI-XhoI sites of pDS3-HA.
HA-F2 (97 ± 323) was constructed by inserting the HaeIIIEcoRV fragment from pDS3-fra-2C into the EcoRV site of pDS3-HA. The expression vector for the c-Jun N-terminal region (amino acids 1 ± 225) fused to 66histidine tag at its Nterminus (pQE30(c-JunCD)) was constructed by inserting the EcoRI-PstI fragment from pCB-wtJ (Abate et al., 1990 (Abate et al., , 1991 into the EcoRI-PstI sites of pQE30 (Qiagen).
Expression and puri®cation of GST fusion proteins
Escherichia coli (DH5 a) transfected with a pGEX derivative was grown in the presence of 0.4 mM IPTG for 1 h at 378C. The cells were chilled on ice, centrifuged at 48C and were suspended in buer S (20 mM Tris-HCl (pH 8.0), 40 mM Na 4 P 2 O 7 , 50 mM NaF, 5 mM MgCl 2 , 100 mM Na 3 VO 4 , 10 mM EGTA, 1% Triton X-100, 0.5% sodium deoxycholate and 0.1% SDS) containing a mixture of protease inhibitors described above. After sonication, cell lysates were centrifuged at 48C and the supernatant was stocked at 7208C.
Cell culture and preparation of cell lysates CEF were prepared from 10-day-old embryos and kept in MEM medium supplemented with 5% CS, 10% TPB and 1% DMSO as described previously (Okuno et al., 1991) . For starvation, cultures were kept in 0.2% CS for 16 h and ). Twenty minutes after u.v. irradiation cell lysates were prepared as described below. CEFs were fully infected with high titer virus stock (subgroup A) of N4 (vsrc carrying virus) or DS3 (the control vector) as described previously . Cultures (60 mm dishes) were metabolically labeled with 0.5 mCi of [
35 S] methionine for 1 h or 1 mCi of [ 32 P]H 3 PO 4 for 2 h as described previously (Yoshida et al., 1989 (Yoshida et al., , 1991 Nishina et al., 1990) . For immunoprecipitation analysis, cell lysates were prepared under denaturing conditions in the presence of phosphatase inhibitors (5 mM Na 3 VO 4 and 10 mM NaF). For in vitro kinase assay, cells were washed twice with PBS and lysed by adding buer S containing a mixture of protease inhibitors. The cell lysates were centrifuged at 15 000 r.p.m. for 10 min at 48C and the supernatant was kept frozen at 7808C. For in gel kinase assay, cells were washed twice with PBS, disrupted by adding the sample buer (61.2 mM Tris-HCl (pH 6.8), 1.96% SDS, 9.8% glycerol and 2.45% b-mercaptoethanol) and boiled for 5 min. Protein amounts were determined by using the BioRad protein assay kit.
Tryptic mapping and phosphoamino acid analysis
After SDS ± PAGE, 32 P-labeled Fra-2 proteins were transferred to polyvinylidine di¯uoride membrane (Millipore Immobilon P). Fra-2 bands were cut out, and the slices were treated with TPCK-trypsin at 378C for 12 h. Digested peptides were boiled in the sample gel buer and subjected to 20% polyacrylamide (acrylamide : bisacrylamide=300 : 1) gel electrophoresis followed by autoradiography. For amino acid analysis, immunoprecipated or puri®ed 32 P-labeled Fra-2 proteins were eluted from the gel slices, subjected to partial acid hydrolysis in 6 N HCl at 1108C and separated by two-dimensional electrophoresis as described previously (Cooper et al., 1983 ; ®rst dimension, pH 1.9; second dimension, pH 3.5). Phosphoamino acid spots were detected by autoradiography.
In gel kinase assay
In gel kinase assays were performed as described previously (Kameshita and Fujisawa, 1989; Hibi et al., 1993) with slight modi®cations. Total cell lysate (15 mg protein) was resolved on a 10% SDS-polyacrylamide gel, which was polymerized either in the absence or presence of puri®ed GST-F2 (215 ± 323) protein (40 mg/ml), MBP (0.5 mg/ml), or the c-Jun N-terminal region (40 mg/ml). After electrophoresis, the gel was washed twice with 125 ml of 20% 2-propanol, 50 mM Tris-HCl (pH 8.0) for 30 min and twice with 125 ml of buer A (50 mM Tris-HCl (pH 8.0) and 5 mM b-mercaptoethanol) for 30 min and incubated with 125 ml of buer A containing 6 M guanidine HCl for 30 min at room temperature. The gels were renaturated by washing twice with buer A containing 0.05% of Tween 40 for 30 min at 48C, and incubated in the same buer for more than 10 h at 48C. Before the kinase reactions, the gels were washed with 90 ml of kinase buer (40 mM Tris-HCl (pH 8.0), 2 mM DTT, 0.1 mM EGTA, 5 mM MgCl 2 ) for 30 min at room temperature. The gel was incubated with the kinase buer containing 20 mM ATP and 5 mCi of [g-32 P]ATP for 60 min at room temperature. the gel was washed 5 times with 100 ml of 5% trichloroacetic acid and 1% sodium pyrophosphate at room temperature. After the gel was dried, protein bands were detected by autoradiography.
In vitro kinase assay GST fusion proteins were mixed with glutathione Sepha rose beads and the mixture was rotated for 90 min at 48C in a 1.5 ml microtube. The beads were pelleted by centrifugation at 10 000 r.p.m. for a few seconds. After three washes with buer S (700 ml each) followed by one wash with 50 mM Tris-HCl (pH 8.0), the pelleted beads were resuspended in 30 ml of kinase buer (10 mM HEPES (pH 7.9), 10 mM MgCl 2 , 20 mM b-glycerophosphate, 0.5 mM Na 3 VO 4 , 1 mM NaF, and 2 mM DTT) containing 10 mM ATP and 5 mCi of [g-32 P]ATP. Twenty nanogram of puri®ed activated MAP kinase (p44 mpk , U.B.I.) or 1 mg protein of cell lysate was added to the kinase reaction mixture, and incubated for 15 min at 308C. The reaction mixture was boiled in the sample gel buer for 5 min to stop the kinase reaction and to elute the proteins from the beads. Eluted proteins were resolved on a 10% SDSpolyacrylamide gel and protein bands were detected by autoradiography.
Immunoprecipitation, Western blotting, and antibodies 35 S-or 32 P-labeled lysates were immunoprecipitated with polyclonal antisera as described previously Yoshida et al., 1989) , except for the inclusion of phosphatase inhibitors. After SDS ± PAGE, protein bands were detected by¯uorography or autoradiography. For Western blotting proteins separated by SDS ± PAGE were transferred to a polyvinylidene di¯uoride membrane (Millipore Immobilon P). Immunoblots were treated with 5% skim milk and incubated with anti-Fra-2 peptide 2 antiserum or anti-HA monoclonal antibody, 12CA5 (Boehringer Mannheim). The membrane was incubated with anti-rabbit immunoglobulin G antibody conjugated to horseradish peroxidase and the protein bands were visualized by use of the ECL Western Blotting Detection System (Amersham). Rabbit polyclonal antibodies raised against Fos peptide 1, Fra-2 peptide 1, Fra-2 peptide 2 and c-Jun expressed in E. coli (anti c-Jun (10)) have been described previously (Yoshida et al., 1989; Nishina et al., 1990; Suzuki et al., 1991a) . Anti-JunD antibody, anti-ERK1 antibody, and anti-ERK2 antibody were purchased from Santa Cruz Biotechnology, Inc.
Transfection and CAT analysis
DNA transfection was performed as described previously (Sonobe et al., 1995) and 48 h after the end of transfection, CEFs were disrupted for the determination of CAT activity. Transfection eciency was normalized on the basis of b-galactosidase activity (Gorman et al., 1982; Yoshida et al., 1993) . The 14 C radioactivity in the spots on TLC plates was quantitated by an image analyser (Fuji BAS 2000) .
